Notice of Frequently Asked Questions for RFA-HL-19-015 "Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)"

Notice Number: NOT-HL-18-629

Key Dates
Release Date: May 18, 2018

Related Announcements
RFA-HL-19-015

Issued by
National Heart, Lung, and Blood Institute (NHLBI)
 

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding applications for RFA-HL-19-015 "Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)”.

The Frequently Asked Questions are available at this site:

https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements-2032

All applicants are strongly encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Henry Chang, MD
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: changh@nhlbi.nih.gov 

Lora Reineck, MD, MS
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI) Telephone: 301-435-0222
Email: lora.reineck@nih.gov

Nicole Redmond, MD, PhD, MPH
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0379
Email: nicole.redmond@nih.gov

Michael M. Engelgau, MD, MS
Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: michael.engelgau@nih.gov